Protagonist Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Protagonist Therapeutics's estimated annual revenue is currently $12.1M per year.
- Protagonist Therapeutics's estimated revenue per employee is $155,000
- Protagonist Therapeutics has 78 Employees.
- Protagonist Therapeutics grew their employee count by 8% last year.
- Protagonist Therapeutics currently has 1 job openings.
What Is Protagonist Therapeutics?
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications. We have successfully utilized this platform to discover PN-943 and PTG-200 which are oral, GI-restricted peptides for inflammatory bowel diseases (IBD), as well as PTG-300, an injectable peptide for rare blood disorders.keywords:N/A